Clinical Trial Investigator Name Stephen Jensik, MD
Clinical Trial Title
Two-year Study of the Safety and Effectiveness of an Investigational Drug in Combination with a Standard Immunosuppressive Regimen
Clinical Trial Protocol Description
Eligible participants will be randomly assigned to receive different strengths of the investigational drug in combination with a standard immunosuppressive regimen or treatment with FDA-approved immunosuppressive drugs. Participants must be willing to participate in extended clinic visits and additional tests. Study-related tests are at no charge.